The fasting plasma glucose is correlated to the prevalence and severity of coronary artery disease in population without diabetes history in Xinjiang, China

References

• Association AD. 2014. Diagnosis and classification of diabetes mellitus. Diabetes Care. 37(Suppl 1):S81–S90.
   PubMedGoogle Scholar
• Bartnik M, Rydén L, Ferrari R, Malmberg K, Pyörälä K, Simoons M, Standl E, Soler-Soler J, Öhrvik J. 2004. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe: the Euro heart survey on diabetes and the heart. Eur Heart J. 25(21):1880–1890.
   PubMed Web of Science ®Google Scholar
• Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M, Lafont S, Bergeonneau C, Kassai B, Erpeldinger S, Wright JM, Gueyffier F, Cornu C. 2011. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. Br Med J. 343:d4169.
   PubMed Web of Science ®Google Scholar
• Buysschaert M, Medina JL, Bergman M, Shah A, Lonier J. 2015. Prediabetes and associated disorders. Endocrine. 48(2):371–393.
   PubMed Web of Science ®Google Scholar
• Capaldo B, Di Bonito P, Iaccarino M, Roman MJ, Lee ET, Devereux RB, Riccardi G, Howard BV, De Simone G. 2013. Cardiovascular characteristics in subjects with increasing levels of abnormal glucose regulation: the strong heart study. Diabetes Care. 36(4):992–997.
   Web of Science ®Google Scholar
• Collaborators GMaCoD. 2015. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of disease study 2013. Lancet. 385(9963):117–171.
   PubMed Web of Science ®Google Scholar
• Coutinho M, Gerstein HC, Wang Y, Yusuf S. 1999. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care. 22(2):233–240.
   PubMed Web of Science ®Google Scholar
• Davidson MB. 2003. Metabolic syndrome/insulin resistance syndrome/pre-diabetes: new section in diabetes care. Diabetes Care. 26(11):3179.
   Web of Science ®Google Scholar
• De Caterina R, Madonna R. 2010. Impaired fasting plasma glucose and long-term cardiovascular risk: still a foggy relationship. Eur Heart J. 31(10):1159–1162.
   Web of Science ®Google Scholar
• Di Angelantonio E, Gao P, Khan H, Butterworth AS, Wormser D, Kaptoge S, Kondapally Seshasai SR, Thompson A, Sarwar N, Willeit P, et al. 2014. Glycated hemoglobin measurement and prediction of cardiovascular disease. Jama. 311(12):1225–1233.
   PubMed Web of Science ®Google Scholar
• Dong X, Zhou L, Zhai Y, Lu B, Wang D, Shi H, Luo X, Fan W, Hu R. 2008. Impaired fasting glucose and the prevalence and severity of angiographic coronary artery disease in high-risk Chinese patients. Metabolism. 57(1):24–29.
   Web of Science ®Google Scholar
• Faerch K, Vistisen D, Johansen NB, Jorgensen ME. 2014. Cardiovascular risk stratification and management in pre-diabetes. Curr Diab Rep. 14(6):493.
   Web of Science ®Google Scholar
• Gao Y, Lu B, Sun ML, Hou ZH, Yu FF, Cao HL, Chen Y, Yang YJ, Jiang SL, Budoff MJ. 2011. Comparison of atherosclerotic plaque by computed tomography angiography in patients with and without diabetes mellitus and with known or suspected coronary artery disease. Am J Cardiol. 108(6):809–813.
   Web of Science ®Google Scholar
• Gensini GG. 1983. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 51(3):606.
   PubMed Web of Science ®Google Scholar
• Hokanson JE, Austin MA. 1996. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a metaanalysis of population-based prospective studies. J Cardiovasc Risk. 3(2):213–219.
   PubMedGoogle Scholar
• Hu FB, Stampfer MJ, Haffner SM, Solomon CG, Willett WC, Manson JE. 2002. Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care. 25(7):1129–1134.
   PubMed Web of Science ®Google Scholar
• Kurihara O, Takano M, Yamamoto M, Shirakabe A, Kimata N, Inami T, Kobayashi N, Munakata R, Murakami D, Inami S, et al. 2013. Impact of prediabetic status on coronary atherosclerosis: a multivessel angioscopic study. Diabetes Care. 36(3):729–733.
   Web of Science ®Google Scholar
• Li N, Wang H, Yan Z, Yao X, Hong J, Zhou L. 2012. Ethnic disparities in the clustering of risk factors for cardiovascular disease among the Kazakh, Uygur, Mongolian and Han populations of Xinjiang: a cross-sectional study. BMC Public Health. 12:499.
   Web of Science ®Google Scholar
• Lorbeer R, Empen K, Dörr M, Arndt M, Schipf S, Nauck M, Wallaschofski H, Felix SB, Völzke H. 2011. Association between glycosylated haemoglobin A1c and endothelial function in an adult non-diabetic population. Atherosclerosis. 217(2):358–363.
   Web of Science ®Google Scholar
• Meadows TA, Bhatt DL, Cannon CP, Gersh BJ, Röther J, Goto S, Liau CS, Wilson PW, Salette G, Smith SC, et al. 2011. Ethnic differences in cardiovascular risks and mortality in atherothrombotic disease: insights from the reduction of atherothrombosis for continued health (REACH) registry. Mayo Clin Proc. 86(10):960–967.
   PubMed Web of Science ®Google Scholar
• Miller G, Miller N. 1975. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet. 305(7897):16–19.
   Google Scholar
• Muntner P, He J, Chen J, Fonseca V, Whelton PK. 2004. Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III). Ann Epidemiol. 14(9):686–695.
   Web of Science ®Google Scholar
• Ok ES, Asci G, Kircelli F, Duman S, Dheir H, Demirci MS, Ozkahya M, Toz H, Ok E. 2012. Relationship between glucose exposure via peritoneal dialysis solutions and coronary artery calcification in non-diabetic peritoneal dialysis patients. Int Urol Nephrol. 44(6):1847–1853.
   Web of Science ®Google Scholar
• Oliveira DS, Tannus LR, Matheus AS, Correa FH, Cobas R, Cunha EF, Gomes MB. 2007. Evaluation of cardiovascular risk according to Framingham criteria in patients with type 2 diabetes. Arq Bras Endocrinol Metabol. 51(2):268–274. Portuguese.
   Google Scholar
• Schinner S, Füth R, Kempf K, Martin S, Willenberg HS, Schott M, Dinh W, Scherbaum WA, Lankisch M. 2011. A progressive increase in cardiovascular risk assessed by coronary angiography in non-diabetic patients at sub-diabetic glucose levels. Cardiovasc Diabetol. 10(1):56.
   Google Scholar
• Tabak AG, Herder C, Rathmann W, Brunner EJ, Kivimaki M. 2012. Prediabetes: a high-risk state for diabetes development. Lancet. 379(9833):2279–2290.
   PubMed Web of Science ®Google Scholar
• Tuso P. 2014. Prediabetes and lifestyle modification: time to prevent a preventable disease. Perm J. 18(3):88–93.
   PubMedGoogle Scholar
• Yan Q, Gu WQ, Hong J, Zhang YF, Su YX, Gui MH, Zhang Y, Chi ZN, Zhang YW, Li XY. 2009. Coronary angiographic studies of impaired glucose regulation and coronary artery disease in Chinese nondiabetic subjects. Endocrine. 36(3):457–463.
   Web of Science ®Google Scholar